Document Detail

Psychopharmacologic treatment of cigarette smoking.
MedLine Citation:
PMID:  2404038     Owner:  NLM     Status:  MEDLINE    
In summary, the entrance of the dental community into this area of treatment may have a significant impact on the reduction of smoking in our society. Dentists may be seeing smokers before the onset of disease and when they are ready to quit. Repeated patient visits offer a unique opportunity for follow-up. Presently, nicotine polacrilex is the only approved pharmacological FDA treatment. This is an ideal treatment for dentists to pursue because it is orally administered and effective through a proper chewing action. Other pharmacological agents (for example, antihypertensives) may require the followup of the physician. There are three key demands on the practitioner treating smokers: an understanding of the role of nicotine dependence in compulsive smoking; how to prescribe and educate in the proper use of nicotine polacrilex; and sympathy and a basic awareness of withdrawal and the psychological needs of patients undergoing cessation from smoking. This paper covers the rationale for development and use of nicotine polacrilex as well as some of the evidence for its effectiveness (relief of nicotine withdrawal) and efficacy (short and long term). The specifics of proper use have been described along with a brief overview of the psychosocial skills needed to succeed. The dentist offers a unique opportunity to reach enormous numbers of smokers in the battle against tobacco-induced disease and death.
N G Schneider
Related Documents :
14725648 - Approaches to tobacco control: the evidence base.
15791678 - Tobacco industry price-subsidizing promotions may overcome the downward pressure of hig...
1548968 - The health benefits of smoking cessation.
3950778 - Smoking and excess sick leave in a department of health.
17761368 - Plasma concentrations of c-reactive protein and total homocysteine in relation to the s...
19395848 - Centeringpregnancysmiles: implementation of a small group prenatal care model with oral...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Journal of the American Dental Association (1939)     Volume:  Suppl     ISSN:  0002-8177     ISO Abbreviation:  J Am Dent Assoc     Publication Date:  1990 Jan 
Date Detail:
Created Date:  1990-02-21     Completed Date:  1990-02-21     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7503060     Medline TA:  J Am Dent Assoc     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  7S-12S     Citation Subset:  D; IM    
UCLA School of Medicine.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Behavior Therapy
Chewing Gum*
Ion Exchange Resins / therapeutic use*
Nicotine / analogs & derivatives*,  therapeutic use
Polymethacrylic Acids / therapeutic use*
Polyvinyls / therapeutic use*
Smoking / psychology,  therapy*
Reg. No./Substance:
0/Chewing Gum; 0/Ion Exchange Resins; 0/Polymethacrylic Acids; 0/Polyvinyls; 54-11-5/Nicotine; 96055-45-7/nicotine polacrilex

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  How-to-do-it quit-smoking strategies for the dental office team: an eight-step program.
Next Document:  Composition and characteristics of glass ionomer cements.